The Patent Finder

Terms ending in 2035

Biodesix, Inc.

Every in-force patent on Biodesix, Inc.'s record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,653,272Mass-Spectral Method for Selection, and De-Selection, of Cancer Patients for Treatment with Immune Response Generating Therapies
In force
 · High confidence
Globeimmune, Inc.In forceHigh confidence
US 9,594,085Integrated Quantification Method for Protein Measurements in Clinical Proteomics
In force
 · High confidence
Biodesix, Inc.In forceHigh confidence
US 9,477,906Classification Generation Method Using Combination of Mini-Classifiers with Regularization and Uses Thereof
In force
 · High confidence
Biodesix, Inc.In forceHigh confidence
US 10,217,620Early Detection of Hepatocellular Carcinoma in High Risk Populations Using Maldi-Tof Mass Spectrometry
In force
 · High confidence
The Board of Regents of the University of Texas SystemIn forceHigh confidence
US 9,563,744Method of predicting development and severity of graft-versus-host disease
In force
 · High confidence
Biodesix Inc.In forceHigh confidence
5 of 5 patents shown. Soonest term end first, then patent number.
3 of these are in force and held by Biodesix, Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited